A treatment timeline of 52 weeks to clear the hepatitis C virus from the body, thankfully, is a thing of the past. Today, treatment horizons continue to get shorter and shorter for hepatitis C infections, with 12 weeks currently being a very typical treatment time for most hepatitis C patients.
Yet, treatment times seem poised to get even more condensed. Achillion Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc. just announced a collaboration agreement with the goal of getting to the marketplace an oral hepatitis C treatment of just six weeks duration. This treatment plan would combine Achillion’s medications called ACH-3102 and ACH-3422 with Janssen’s sovaprevir. The result, the companies hope, will be a short-duration, simplified treatment option that would be available by 2018.
If this medication combination lives up to early results, it would be effective for all hepatitis C genotypes, providing a cure in just six weeks. What a welcome addition to treatment options this would be!
Kolonko C. Two companies enter into hepatitis C drug development deal. HCPlive.com May 22, 2015.